Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥14.93 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	22.57
Forward PE	11.88
Price to Sales TTM	CN¥3.88
Price to Book MRQ	CN¥2.13
Enterprise to Revenue	3.75
Enterprise to EBITDA	17.91

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	17.28%
Operating Margin	10.04%
Return on Assets TTM	3.81%
Return on Equity TTM	9.98%

Income Statement

Revenue TTM	CN¥3,761,320,704
Revenue per Share TTM	CN¥2.37
Quarterly Revenue Growth	0.10%
Gross Profit TTM	CN¥1,687,896,576
EBITDA	CN¥742,071,420
Net Income to Common TTM	CN¥649,827,712
Diluted EPS TTM	CN¥0.40
Quarterly Earnings Growth YoY	-28.70%

Balance Sheet

Total Cash MRQ	CN¥2,699,294,208
Total Cash per Share MRQ	CN¥1.70
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	35.92
Current Ratio MRQ	2.46
Book Value per Share MRQ	CN¥4.25

Cash Flow

Operating Cash Flow TTM	CN¥1,346,475,520
Levered Free Cash Flow TTM	CN¥566,096,256

603707 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	1,615,634,969
Float Shares	434,101,644
Avg 10 Volume	7,591,614
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	72.73%
% Held by Institutions	8.20%

Stock Price Summary

Beta	0.65
Fifty Two Week Low	CN¥9.00
Fifty Two Week High	CN¥14.86
Fifty Two Week Change	-37.65%
Day 50 MA	CN¥9.69
Day 200 MA	CN¥10.85

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.40
Forward Annual Dividend Yield	4.43%
Trailing Annual Dividend Rate	CN¥0.10
Trailing Annual Dividend Yield	1.11%
Payout Ratio	25.00%
Dividend Date
Ex Dividend Date	2025-06-05
Last Split Factor
Last Split Date	2022-07-11